Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
SCHILLER AG
AMPRONIX

MRI System Employs New Magnet Technology for Superior Image Quality

By Medimaging International staff writers
Posted on 31 Oct 2013
Image: Toshiba’s Vantage Elan 1.5 T MRI system (Photo courtesy of Toshiba).
Image: Toshiba’s Vantage Elan 1.5 T MRI system (Photo courtesy of Toshiba).
A next-generation 1.5 T magnetic resonance imaging (MRI) system provides excellent intrinsic homogeneity by employing a new magnet technology. The technology also provides excellent image quality even in the most difficult examination requirements such as off-center imaging or in a large field-of-view requiring fat-free images.

Toshiba Medical Systems Corp. (Tokyo, Japan) presented its new 1.5 T MRI system at the Journées Françaises de la Radiologie (French Radiology Congress), held in Paris (France) from October the 18-22, 2013. With more than 1,700 systems already installed worldwide, the Vantage range of MRI scanners provided a strong technologic basis for the new design of the Vantage Elan.

The developers of the system have improved the comfort of the scanning procedure by introducing a new technology called Pianissimo Σ, which substantially reduces the noise for the patient and the operator. The new light coil design with Octave SPEEDER technology provides easier set up and a more comfortable experience for the patient without sacrificing image quality. Feet first examination technique also helps to reduce patient anxiety. Finally, the new bore aperture, short length magnet and air flow system, provides the patient with a comfortable place to have their examination with less stress.

The new technology now makes it possible to perform a full body noncontrast MR angiography (MRA). Toshiba developed the technique to remove the need to use expensive and potentially harmful contrast media while still providing contrast in the images. Toshiba has saved users from choosing to inject contrast media in their patients while giving them even better information without the problems that contrast can cause in obscuring fine details.

Toshiba’s M-Power software allows the user to rapidly and easily learn and access all of sophisticated software techniques. With high SPEEDER factors and the ability to use versatile 16ch Flex coils, one can get the best images in the least time with the greatest comfort for patients. Atlas Compass technology selects the best elements to perform the imaging procedure.

More importantly, the Vantage Elan is eco-friendly as this system strongly reduces it power consumption through the Eco mode. In conventional MRI systems, power is supplied to various subsystems even while in standby mode in order to maintain a stable system operation. The Vantage Elan provides a novel Eco mode in which power is supplied to fewer subsystems while maintaining stable operation, simultaneously saving money and helping the environment.

The Vantage Elan only requires 23 square meters for a complete installation accomplished in only one week. The system maximizes performance while reducing space requirement, establishing a new segment for the 1.5T image space.

Related Links:

Toshiba Medical Systems



RADCAL
SuperSonic Imagine
RTI ELECTRONICS AB

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.